Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Delayed Graft Function: full-pipeline trial registry
2 of 7 indexed Delayed Graft Function trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Delayed Graft Function: 7 US clinical trials tracked, 2 recruiting.
Delayed Graft Function is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is West Penn Allegheny Health System, running 1 of these trials.
Enrollment posture brief
Registry condition delayed-graft-function
OPEN 2 | RECR 29% | LATE 3 | EARLY 3 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Delayed Graft Function lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Delayed Graft Function on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Delayed Graft Function is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Delayed Graft Function trials is spread across many organizations.
West Penn Allegheny Health System accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Delayed Graft Function enrolment sits around 100 participants.
Median target enrolment is 100 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.
-
Delayed Graft Function research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Alexion Pharmaceuticals
NCT06830798
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
Rhode Island Hospital
NCT04005469
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
argenx
NCT05907096
Deceased Organ Donor Interventions to Protect Kidney Graft Function
University of California, San Francisco
NCT02525510
Envarsus in Delayed Graft Function (E-DGF)
University of Wisconsin, Madison
NCT03864926
Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
West Penn Allegheny Health System
NCT00425126
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
Cedars-Sinai Medical Center
NCT02134314
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Delayed Graft Function records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Delayed Graft Function trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Delayed Graft Function page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Delayed Graft Function trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- West Penn Allegheny Health System sponsors the most Delayed Graft Function trials on record, review their full trial history before evaluating a specific study. See West Penn Allegheny Health System's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Delayed Graft Function condition card totals 7 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.